Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease
- PMID: 40243387
- PMCID: PMC12005123
- DOI: 10.1002/ppul.71096
Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease
Abstract
The field of pediatric rare and diffuse lung diseases continues to advance, with ongoing research deepening our understanding of the diagnosis and treatment of conditions such as children's interstitial and diffuse lung disease (chILD), non-cystic fibrosis (CF) bronchiectasis, and pulmonary complications of childhood cancer. Recent publications in Pediatric Pulmonology and other journals in 2024 have highlighted new insights into the pathophysiology, disease progression, and emerging diagnostic tools for these rare lung conditions, as well as innovative therapeutic approaches. This review features these important advancements within the context of current diagnostic practices and clinical care for pediatric patients with rare and diffuse lung diseases.
Keywords: bronchiectasis; bronchiolitis obliterans syndrome; interstitial lung disease; primary ciliary dyskinesia; stem cell transplantation.
© 2025 The Author(s). Pediatric Pulmonology published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
